1-4 of 4
Joth Jacobson
Close
Sort by
Journal Articles

Treatment of multiple myeloma

Bart Barlogie, John Shaughnessy, Guido Tricot, Joth Jacobson, Maurizio Zangari, Elias Anaissie, Ron Walker, John Crowley
Journal: Blood
Blood (2004) 103 (1): 20–32.
https://doi.org/10.1182/blood-2003-04-1045
Published: 2004
Journal Articles

Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival

Clinical Trials & Observations
Kai-Da Wu, Lisa M. Orme, John Shaughnessy, Jr, Joth Jacobson, Bart Barlogie, Malcolm A. S. Moore
Journal: Blood
Blood (2003) 101 (12): 4982–4989.
https://doi.org/10.1182/blood-2002-11-3451
Published: 2003
Journal Articles

Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression

Clinical Trials & Observations
John Shaughnessy, Joth Jacobson, Jeff Sawyer, Jason McCoy, Athanasios Fassas, Fenghuang Zhan, Klaus Bumm, Joshua Epstein, Elias Anaissie, Sundar Jagannath, David Vesole, David Siegel, Raman Desikan, Nikhil Munshi, Ashraf Badros, Erming Tian, Maurizio Zangari, Guido Tricot, John Crowley, Bart Barlogie
Journal: Blood
Blood (2003) 101 (10): 3849–3856.
https://doi.org/10.1182/blood-2002-09-2873
Published: 2003
Journal Articles

Superiority of Tandem Autologous Transplantation Over Standard Therapy for Previously Untreated Multiple Myeloma

Bart Barlogie, Sundar Jagannath, David H. Vesole, Sally Naucke, Bruce Cheson, Sandy Mattox, Dwayne Bracy, Sydney Salmon, Joth Jacobson, John Crowley, Guido Tricot
Journal: Blood
Blood (1997) 89 (3): 789–793.
https://doi.org/10.1182/blood.V89.3.789
Published: 1997